|
ALION SCIENCE & TECHNOLOGY CORP - 10-K - 20031224 - CASH_FLOW
SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
Consolidated Statements of Cash Flow
For the years ended September 30, 2002, 2001, and 2000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended September 30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2002
|
|
2001
|
|
2000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands)
|
|
|
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (loss)
|
|
$
|
4,698
|
|
|
$
|
9,497
|
|
|
$
|
4,282
|
|
|
|
|
Adjustments to reconcile net income loss to net cash provided by (used in)
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
3,447
|
|
|
|
3,488
|
|
|
|
3,754
|
|
|
|
|
|
Gain in investments
|
|
|
(77
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
Equity in loss of affiliate
|
|
|
—
|
|
|
|
—
|
|
|
|
498
|
|
|
|
|
|
Amortization of deferred gain on sale of building to the Illinois
Institute of Technology
|
|
|
(486
|
)
|
|
|
(379
|
)
|
|
|
—
|
|
|
|
|
|
Gain on sale of land
|
|
|
—
|
|
|
|
—
|
|
|
|
(1,319
|
)
|
|
|
|
|
Loss on disposal of fixed assets
|
|
|
—
|
|
|
|
84
|
|
|
|
—
|
|
|
|
|
|
Changes in assets and liabilities, net of effect of acquisitions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable, net
|
|
|
5,927
|
|
|
|
378
|
|
|
|
(8,369
|
)
|
|
|
|
|
|
Other assets
|
|
|
(654
|
)
|
|
|
(365
|
)
|
|
|
1,088
|
|
|
|
|
|
|
Trade accounts payable and accrued liabilities
|
|
|
4,384
|
|
|
|
(1,696
|
)
|
|
|
(136
|
)
|
|
|
|
|
|
Other liabilities
|
|
|
(2,526
|
)
|
|
|
(3,100
|
)
|
|
|
(5,104
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) operating activities
|
|
|
14,713
|
|
|
|
7,907
|
|
|
|
(5,306
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from sale of land
|
|
|
—
|
|
|
|
—
|
|
|
|
2,328
|
|
|
|
|
Proceeds from sale of building to the Illinois Institute of Technology, net
|
|
|
—
|
|
|
|
12,181
|
|
|
|
—
|
|
|
|
|
Capital expenditures
|
|
|
(3,643
|
)
|
|
|
(1,940
|
)
|
|
|
(2,795
|
)
|
|
|
|
Cash paid for acquisition of net assets of AB Tech
|
|
|
—
|
|
|
|
(378
|
)
|
|
|
(2,500
|
)
|
|
|
|
Cash paid for Daedelic
|
|
|
(823
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities
|
|
|
(4,466
|
)
|
|
|
9,863
|
|
|
|
(2,967
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase in (repayment of) bank overdraft
|
|
|
(2,156
|
)
|
|
|
2,156
|
|
|
|
855
|
|
|
|
|
Net borrowings (repayments) under revolving bank credit agreement
|
|
|
(7,526
|
)
|
|
|
(10,838
|
)
|
|
|
14,373
|
|
|
|
|
Payments under notes payable
|
|
|
(141
|
)
|
|
|
(3,649
|
)
|
|
|
(6,817
|
)
|
|
|
|
Distributions to the Illinois Institute of Technology
|
|
|
(887
|
)
|
|
|
(1,585
|
)
|
|
|
(1,315
|
)
|
|
|
|
Unreimbursed losses and capital funding (of) from Life Sciences Operation
|
|
|
859
|
|
|
|
(3,854
|
)
|
|
|
(2,135
|
)
|
|
|
|
Cash transferred to Alion in conjunction with the sale of the Business to
Alion
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
(9,851
|
)
|
|
|
(17,770
|
)
|
|
|
4,961
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash
|
|
|
396
|
|
|
|
—
|
|
|
|
(3,312
|
)
|
|
Cash at beginning of period
|
|
|
—
|
|
|
|
—
|
|
|
|
3,312
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash at end of period
|
|
$
|
396
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplement disclosure of cash flow information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for interest
|
|
$
|
776
|
|
|
$
|
1,561
|
|
|
$
|
1,318
|
|
|
|
|
Cash paid for income taxes
|
|
|
489
|
|
|
|
570
|
|
|
|
—
|
|
|
Supplemental disclosure of noncash financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt incurred related to earnout provisions of acquisitions
|
|
$
|
624
|
|
|
$
|
579
|
|
|
$
|
2,952
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Next Section
Previous Section